CardioDynamics Announces Significant ICG Study with Nearly Three Times the National Average Blood Pressure Control Rates at the American Society for Hypertension Annual Scientif...( Blood Pressure Control Doubled wit...),Health

Blood Pressure Control Doubled with ICG-Guided Therapy On Over 76,000+

Patient Visits

SAN DIEGO, May 15 /PRNewswire-FirstCall/ -- CardioDynamics (Nasdaq: CDICD), the innovator and leader of Impedance Cardiography (ICG) technology and manufacturer of BioZ(R) noninvasive cardiac monitoring systems, today announced the presentation of a significant independent ICG clinical study at the Twenty-third Annual American Society for Hypertension (ASH) Scientific Meeting in New Orleans, Louisiana.

Study results were reported from a 65 physician primary care and cardiology group practice and demonstrated an impressive 102% improvement in blood pressure control rates, with control rates improving from 42% to 88%. Over 76,000 patient visits were included in the analysis.

Robert E. Matthews, Executive Director, PriMed Physicians, Dayton Ohio, stated, "Our physician group has set strategic goals to achieve nationally recognized levels of clinical and service quality, particularly chronic disease management including hypertension. We used a Six Sigma quality approach to develop a process for the treatment of patients diagnosed with hypertension and we incorporated the use of BioZ ICG to guide antihypertensive therapy selection in patients whose blood pressure was not at goal. Our analysis clearly and repeatedly showed that the use of ICG was a significant contributor to whether or not the patient achieved goal blood pressure and allowed us to achieve the highest known hypertension control rate of all group practices in the United States."

Douglas Magenheim, M.D., M.B.A, Medical Director for PriMed, initially piloted use of the BioZ ICG and found that it significantly improved his ability to help achieve appropriate hypertension control. Based upon his experience, the group initially included BioZ ICG in the Hypertension quality process and measured whether, in fact, it would be an effective, value added step in chang
'/>"/>